Unclaimed
Raymond F. Schinazi
Is this your profile? Claim & update it for free.
This profile was programmatically compiled from public sources. Take control to ensure accuracy, share updates, and connect with industry R&D teams.
Discovery of broad-spectrum antivirals targeting viral proteases using in silico structural modeling and cellular analysis
2025
Human<i>ribomes</i>reveal DNA-embedded ribonucleotides as a new type of epigenetic mark
bioRxiv (Cold Spring Harbor Laboratory)
•2025
Loss of the aryl hydrocarbon receptor promotes cancer cell resistance to BRAFV600E targeted therapies
Signal Transduction and Targeted Therapy
•2025
Independent Assessment of a Point of Care HCV RNA Test by Laboratory Analytical Testing and a Prospective Field Study in the U.S.
2025
Towards diagnostic preparedness: detection of highly pathogenic avian influenza A(H5N1) in contrived nasal swab specimens using rapid antigen and point-of-care molecular tests
2025
Combating yellow fever virus with 7-deaza-7-fluoro-2′-C-methyladenosine
Antimicrobial Agents and Chemotherapy
•2025
Broad-Spectrum Antiviral Efficacy of 7-Deaza-7-Fluoro-2'-C-Methyladenosine Against Multiple Coronaviruses In Vitro and In Vivo
bioRxiv (Cold Spring Harbor Laboratory)
•2025
Reader Comment on: “Comprehensive genotoxicity and carcinogenicity assessment of molnupiravir”
2024
The Discovery and Preclinical Profile of ALG-000184, a Prodrug of the Potent Hepatitis B Virus Capsid Assembly Modulator ALG-001075
2024
Partner smarter. Move faster.
Get new partnering requests
delivered to your inbox.
delivered to your inbox.
© 2026 Halo Cures, Inc.